downgraded at Citigroup to Neutral from Buy, Citigroup said. $60 price target. Limited upside after recent outperformance.
upgraded at Miller Tabak from Hold to Buy, Miller Tabak said. $190 price target. Company has the best sales prospects in the industry.
downgraded at Craig-Hallum from Buy to Hold, Craig-Hallum said. $17 price target. Company has limited near-term visibility.
(UAL - Get Report)
downgraded at BofA/Merrill to Underperform, Bank of America/Merrill Lynch said. Estimates also cut, given the company's new guidance. $22 price target.
STOCK COMMENTS / EPS CHANGES
numbers raised at Jefferies. Shares of AOS now seen reaching $80, Jefferies said. Estimates also raised on developing residential recovery. Buy rating.
numbers reduced at Sterne Agee. Shares of CRUS now seen reaching $42, according to Sterne Agee. Estimates also cut, given the company's new guidance. Buy rating.
target raised at Oppenheimer to $245, Oppenheimer said. January to sales up from December. Outperform rating.
target raised at Oppenheimer to $101, Oppenheimer said. Strong execution through challenging markets. Outperform rating.
estimates, target increased at BMO. INFA estimates were raised through 2014, BMO Capital said. Company is leveraged to higher spending on data software. Market Perform rating.
JB Hunt Transport
numbers raised at Jefferies. Shares of JBHT now seen reaching $70, Jefferies said. Estimates also raised on outperformance of intermodal. Hold rating.
estimates, target upped at BofA/Merrill. JNPR estimates were boosted through 2014, Bank of America/Merrill Lynch said. Higher sales are driving margin expansion. Buy rating and new $25 price target.
numbers boosted at Credit Suisse. Shares of KLAC now seen reaching $63, according to Credit Suisse. Estimates also upped, as the company is seeing higher customer spending.
numbers raised at Jefferies. Shares of LMT now seen reaching $95, Jefferies said. Estimates also raised on smart capital allocation. Hold rating.
Lockheed Martin numbers raised at Credit Suisse. Shares of LMT now seen reaching $93, according to Credit Suisse. Estimates also increased, as the company is realizing higher margins. Neutral rating.
numbers upped at BMO through 2014, BMO Capital said. Company continues to execute well. Market Perform rating and new $30 price target.
cut from Conviction Buy List at Goldman. ORCL was removed from the Conviction Buy list, Goldman Sachs said. Company has limited earnings upside potential. $39 price target.
estimates, target increased at BMO through 2015, BMO Capital said. Company is seeing higher sales across the board. Market Perform rating and new $48 price target.